Plants for delivery of edible vaccines.
Over the past decade, scientific advances in molecular biology and immunology have improved understanding of many diseases and led to the development of novel strategies for vaccination. The development of plants expressing vaccine antigens is a particularly promising approach. Plant-derived antigenic proteins have delayed or prevented the onset of disease in animals and have proven to be safe and functional in human clinical trials. Future areas of research should further characterize the induction of the mucosal immune system and appropriate crop species for delivery of animal and human vaccines.
Walmsley
A M
AM
Boyce Thompson Institute for Plant Research, Cornell University, Ithaca, NY 14853, USA. amw21@cornell.edu
Arntzen
C J
CJ
D000284:Administration, Oral; D000818:Animals; D005818:Genetic Engineering / Q000379:methods*; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D018928:Immunity, Mucosal; D010330:Patents as Topic; D010944:Plants / Q000235:genetics* / Q000821:virology; D012231:Rhizobium / Q000235:genetics; D014170:Transformation, Genetic / Q000235:genetics; D014614:Vaccines, Synthetic / Q000008:administration & dosage* / Q000235:genetics*
D014614:Vaccines, Synthetic